Skip to content

Home - Media - Press releases - 2002    
14 November 2002
ASTRAZENECA PLC – DIRECTORATE ANNOUNCEMENT

AstraZeneca PLC today announced that Åke Stavling will be leaving the Company on 31 January 2003. Åke Stavling is 58 and has been an Executive Director since April 1999. He played a key role in the integration of Astra and Zeneca following the merger in 1999 and since then has been responsible for Business Development. From 1993-1999 he was Executive Vice President and Chief Financial Officer of Astra AB and before that held senior positions at Atlas Copco and Ericsson.

Sir Tom McKillop, Chief Executive, AstraZeneca said ‘Åke Stavling has made an important contribution to the success of AstraZeneca and he leaves AstraZeneca with our thanks and best wishes for the future’.

Åke Stavling’s responsibilities for Business Development will transfer to John Patterson, Executive Vice President, AstraZeneca.

Further enquires to:

Media Enquiries

Steve Brown
+44 (0)20 7304 5033

Emily Denney
+44 (0)20 7304 5034


Investor Relations

Mina Blair-Robinson
+44 (0)20 7304 5084

Jonathan Hunt
+44 (0)20 7304 5087
AstraZeneca websites
Search
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008